Ranking Drug Targets in Tuberculosis
Author Information
Author(s): Hasan Samiul, Daugelat Sabine, Rao P. S. Srinivasa, Schreiber Mark
Primary Institution: Novartis Institute for Tropical Diseases (NITD), Chromos, Singapore
Hypothesis
Can a software program effectively prioritize genomic drug targets in Mycobacterium tuberculosis?
Conclusion
The software AssessDrugTarget can effectively prioritize potential drug targets in Mycobacterium tuberculosis, aiding in the search for new treatments.
Supporting Evidence
- The software can quickly produce prioritized lists of drug targets.
- It integrates public genomic data effectively for drug target prioritization.
- The approach can be extended to other pathogens beyond Mycobacterium tuberculosis.
Takeaway
Researchers created a computer program to help find the best genes to target for new tuberculosis drugs, making it easier to discover new treatments.
Methodology
The study developed a software program that integrates various genomic data to rank genes as potential drug targets based on specific criteria.
Potential Biases
Potential bias exists in the selection of features and weights used in the software for prioritizing drug targets.
Limitations
The study's findings are limited by the availability of genomic data and the complexity of the persistence state in M. tuberculosis.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% confidence level
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website